Patient Leaflet Updated 18-Jun-2024 | Rosemont Pharmaceuticals Limited
Pregabalin Rosemont 20mg/ml Oral Solution
Pregabalin Rosemont 20mg/ml Oral Solution
pregabalin
1. What Pregabalin Rosemont is and what it is used for
2. What you need to know before you take Pregabalin Rosemont
3. How to take Pregabalin Rosemont
4. Possible side effects
5. How to store Pregabalin Rosemont
6. Contents of the pack and other information
Pregabalin belongs to a group of medicines used to treat epilepsy, neuropathic pain and Generalised Anxiety Disorder (GAD) in adults.
Pregabalin is used to treat long lasting pain caused by damage to the nerves. A variety of diseases can cause peripheral neuropathic pain, such as diabetes or shingles. Pain sensations may be described as hot, burning, throbbing, shooting, stabbing, sharp, cramping, aching, tingling, numbness, pins and needles. Peripheral and central neuropathic pain may also be associated with mood changes, sleep disturbance, fatigue (tiredness), and can have an impact on physical and social functioning and overall quality of life.
Pregabalin is used to treat a certain form of epilepsy (partial seizures with or without secondary generalisation- epileptic fits starting on one specific part of the brain) in adults. Your doctor will prescribe pregabalin for you to help treat your epilepsy when your current treatment is not controlling your condition. You should take pregabalin in addition to your current treatment.
Pregabalin is not intended to be used alone, but should always be used in combination with other anti-epileptic treatment.
Pregabalin is used to treat Generalised Anxiety Disorder (GAD). The symptoms of GAD are prolonged excessive anxiety and worry that are difficult to control. GAD can also cause restlessness or feeling keyed up or on edge, being easily fatigued (tired), having difficulty concentrating or mind going blank, feeling irritable, having muscle tension or sleep disturbance. This is different to the stresses and strains of everyday life.
If you are allergic to pregabalin or any of the other ingredients of this medicine (listed in section 6).
Talk to your doctor or pharmacist before taking pregabalin.
Some people may become dependent on Pregabalin (a need to keep taking the medicine). They may have withdrawal effects when they stop using Pregabalin (see section 3, “How to take Pregabalin” and “If you stop taking Pregabalin”). If you have concerns that you may become dependent on Pregabalin, it is important that you consult your doctor.
If you notice any of the following signs whilst taking Pregabalin, it could be a sign that you have become dependent:
If you notice any of these, speak to your doctor to discuss the best treatment pathway for you, including when it is appropriate to stop and how to do this safely.
The safety and efficacy in children and adolescents (under 18 years of age) has not been established and therefore, pregabalin should not be used in this age group.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Pregabalin and certain other medicines may influence each other (interaction). When taken with certain other medicines, which have sedative effects (including opioids), pregabalin may potentiate these effects and could lead to respiratory failure, coma and death. The degree of dizziness, sleepiness and decreased concentration may be increased if pregabalin is taken together with medicines containing:
Pregabalin may be taken with oral contraceptives.
Pregabalin may be taken with or without food.
It is advised not to drink alcohol while taking Pregabalin.
Pregabalin should not be taken during pregnancy or when breast-feeding, unless you are told otherwise by your doctor. Pregabalin use during the first 3 months of pregnancy may cause birth defects in the unborn child that require medical treatment. In a study reviewing data from women in Nordic countries who took pregabalin in the first 3 months of pregnancy, 6 babies in every 100 had such birth defects. This compares to 4 babies in every 100 born to women not treated with pregabalin in the study. Abnormalities of the face (orofacial clefts), the eyes, the nervous system (including the brain), kidneys and genitals have been reported.
Effective contraception must be used by women of childbearing potential. If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregabalin may produce dizziness, sleepiness and decreased concentration. You should not drive, operate complex machinery or engage in other potentially hazardous activities until you know whether this medicine affects your ability to perform these activities.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
Your doctor will determine what dose is appropriate for you.
If you have the impression that the effect of this medicine is too strong or too weak, talk to your doctor or pharmacist.
If you are an elderly patient (over 65 years of age), you should take this medicine normally except if you have problems with your kidneys.
Your doctor may prescribe a different dosing schedule and/or dose if you have problems with your kidneys.
Continue taking this medicine until your doctor tells you to stop.
Pregabalin Rosemont is for oral use only.
1. Open the bottle: Press downward on the cap and turn it counter-clockwise (Figure 1).
2. First time use only: A Press-In Bottle Adapter (PIBA) is provided with the oral syringe. This is the device that gets inserted into the neck of the bottle to make it easier to withdraw the solution using the oral syringe. If the PIBA is not already in place, remove the PIBA and 5 ml oral syringe from the plastic overwrap. With the bottle on a flat surface, insert the PIBA into the bottle neck while keeping the PIBA’s flat surface facing up and pressing on it (Figure 2).
3. Push the syringe plunger to the bottom of the barrel of the syringe (toward its tip) to remove excess air. Attach the syringe to the PIBA with a slight twisting motion (Figure 3).
4. Invert the bottle (with the syringe attached) and fill the syringe with the liquid by pulling the syringe plunger down to just beyond the graduation mark corresponding to the quantity in millilitres (ml) prescribed by your doctor (Figure 4). Remove air bubbles from the syringe by pushing the plunger up to the appropriate graduation mark.
5. Return the bottle to an upright position with the syringe still in the PIBA/bottle (Figure 5).
6. Remove the syringe from the bottle/PIBA (Figure 6).
7. Empty the contents of the syringe directly into mouth by pushing the syringe plunger to the bottom of the syringe barrel (Figure 7).
Note: Steps 4-7 may need to be repeated up to three times to obtain the total dose (Table 1).
[For example, a 150 mg (7.5 ml) dose will require two withdrawals from the bottle to achieve the entire dose. Using the oral syringe, first withdraw 5 ml and empty contents of syringe directly into the mouth, then refill the oral syringe with 2.5 ml and empty the remaining contents into the mouth.]
8. Rinse the syringe by drawing water into the syringe and pushing the syringe plunger to the bottom of the syringe barrel, at least three times (Figure 8).
9. Replace the cap on the bottle (leaving the PIBA in place in the bottle neck) (Figure 9).
Oral Syringe Withdrawals to Deliver Prescribed Dose of Pregabalin Rosemont
Pregabalin Rosemont Dose: 25
Total Solution Volume (ml): 1.25
First Syringe Withdrawal (ml): 1.25
Second Syringe Withdrawal (ml): Not required
Third Syringe Withdrawal (ml): Not required
Pregabalin Rosemont Dose: 50
Total Solution Volume (ml): 2.5
First Syringe Withdrawal (ml): 2.5
Second Syringe Withdrawal (ml): Not required
Third Syringe Withdrawal (ml): Not required
Pregabalin Rosemont Dose: 75
Total Solution Volume (ml): 3.75
First Syringe Withdrawal (ml): 3.75
Second Syringe Withdrawal (ml): Not required
Third Syringe Withdrawal (ml): Not required
Pregabalin Rosemont Dose: 100
Total Solution Volume (ml): 5
First Syringe Withdrawal (ml): 5
Second Syringe Withdrawal (ml): Not required
Third Syringe Withdrawal (ml): Not required
Pregabalin Rosemont Dose: 150
Total Solution Volume (ml): 7.5
First Syringe Withdrawal (ml): 5
Second Syringe Withdrawal (ml): 2.5
Third Syringe Withdrawal (ml): Not required
Pregabalin Rosemont Dose: 200
Total Solution Volume (ml): 10
First Syringe Withdrawal (ml): 5
Second Syringe Withdrawal (ml): 5
Third Syringe Withdrawal (ml): Not required
Pregabalin Rosemont Dose: 225
Total Solution Volume (ml): 11.25
First Syringe Withdrawal (ml): 5
Second Syringe Withdrawal (ml): 5
Third Syringe Withdrawal (ml): 1.25
Pregabalin Rosemont Dose: 300
Total Solution Volume (ml): 15
First Syringe Withdrawal (ml): 5
Second Syringe Withdrawal (ml): 5
Third Syringe Withdrawal (ml): 5
Call your doctor or go to the nearest hospital emergency unit immediately. Take your box or bottle of Pregabalin Rosemont with you. You may feel sleepy, confused, agitated, or restless as a result of taking more pregabalin than you should. Fits have been reported.
It is important to take your Pregabalin Rosemont regularly at the same time each day. If you forget to take a dose, take it as soon as you remember unless it is time for your next dose. In that case, just carry on with the next dose as normal. Do not take a double dose to make up for a forgotten dose.
Do not stop taking pregabalin unless your doctor tells you to. If your treatment is stopped it should be done gradually over a minimum of 1 week.
After stopping long and short-term pregabalin treatment, you need to know that you may experience certain side effects. These include, trouble sleeping, headache, nausea, feeling anxious, diarrhoea, flu-like symptoms, convulsions, nervousness, depression, pain, sweating, and dizziness. These symptoms may occur more commonly or severely if you have been taking pregabalin for a longer period of time.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1000 people
Very rare: may affect up to 1 in 10,000 people
Not known: frequency cannot be estimated from the available data
After stopping a short or long-term treatment with Pregabalin, you need to know that you may experience certain side effects, so-called withdrawal effects (see “If you stop taking Pregabalin”)
If you experience swollen face or tongue or if your skin turns red and starts to blister or peel you should seek immediate medical advice.
Certain side effects may be more common, such as sleepiness, because patients with spinal cord injury may be taking other medicines to treat, for example, pain or spasticity, that have similar side effects to pregabalin and the severity of these effects may be increased when taken together.
The following adverse reaction has been reported in the postmarketing experience: Trouble breathing, shallow breaths.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
The active substance is pregabalin. Each ml contains 20 mg pregabalin.
The other ingredients are: methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216), sodium dihydrogen phosphate anhydrous, Disodium phosphate, sucralose, strawberry flavouring 10131/P [contains E414 arabic gum, dextrose monohydrate, maltodextrine, flavouring substances regulated by 1334/2008/CE], purified water.
Pregabalin Rosemont 20 mg/ml oral solution is a clear colourless solution in a white plastic bottle containing 473 ml of oral solution, in a cardboard carton. The carton also contains a white, plastic 5ml oral syringe with 1.25ml graduations and a white, plastic press-in bottle adapter (PIBA).
Marketing Authorisation Holder:
Manufacturer:
This leaflet was last revised in 05/2024
PREG.RO.LEAF.20.473.7
D7G77RBJ7_V2
Rosemont House, Yorkdale Industrial Park, Braithwaite Street, Leeds, Yorkshire, LS11 9XE
+44 (0)113 245 3567
+44 (0)800 919 312
+44 (0)795 762 3515
+44 (0)113 244 1400
http://www.rosemontpharma.com